 |
Human prothrombin complex concentrate |
|---|---|
| Trade Name | Octaplex |
| Orphan Indication | Reversal of anticoagulation therapy in patients needing treatment of serious or life threatening bleeding and/or needing urgent surgery or invasive procedures |
| USA Market Approval | USA |
| USA Designation Date | 2008-02-01 00:00:00 |
| Sponsor | Octapharma USA, Inc.;121 River Street, 12th Floor;Hoboken, New Jersey, 07030 |
